Ar dtús léirithe i 1973 ag Ralph Steinman agus Zanvil Cohn, tá post bunúsach ag cealla dendritic (DCanna) cur isteach ar fhrithghníomhartha do-ghlactha intreach agus freagairt imdhíonachta solúbtha a chothú. Ón bpointe sin ar aghaidh, breathnaíodh ar DCanna mar na cealla is déine a thaispeánann antaiginí (APCanna), ar a dtugtar “Aidiúvach an Dúlra” go minic, atá deartha chun imoibrithe creidiúnacha agus cuimhne-resistant a thionscnamh. I dtéarmaí antaiginí a dhaingniú agus a bhainistiú le tabhairt isteach i gcealla T, tá teorainn fhorleithne ag DCanna agus cuireann siad cainníochtaí neamhghnácha in iúl d'adamh costimulatory nó coinhibitory a chinneann tionscnamh slán nó aimhréidh1. Timpeall 40 bliain ina dhiaidh sin, nuair a bronnadh an Duais Nobel don Leigheas nó don Fhiseolaíocht ar Ralph Steinman in 2011 as na cealla imdhíonachta nádúrtha riachtanacha seo a nochtadh, measadh a thábhachtaí atá DCanna.
seo immunotherapy treatment helps the body battle cancer cells with its own defense mechanism. Dendritic cell therapy is often used when regular therapies have not been effective. As of late, this treatment was proposed in India and multiple patients were relieved under the supervision of the renowned Oncologist with empowering results. Be that as it may, there are common drugs that have been developed over decades for most forms of meall. Usage of these drugs is administered and combined with unsusceptible care, since it is realized that tumor cells weakened by chemotherapy or radiation are considerably easier to decimate with invulnerable cells than with flawless tumor cells.
An cineál ailse a chóireáiltear le cóireáil imdhíonteiripe dendritic-bhunaithe
- Ailse craicinn
- Ailse duáin
- Ailse chíche
- ailse paincréasach
- Ailse Colon
- Ailse ubhagáin
- Ailse próstatach
Céim IV cóireáil ailse
Dendritic cell based immunotherapy treatment has proved to be quite a success specially with no hope stage IV cancer treatment. Patients specially on stage IV cancer can try and go for dendritic cell based immunotherapy in cancer treatment.
Ospidéil le haghaidh cóireáil imdhíonteiripe dendritic-bhunaithe ceall san India
- LDG India Teo, Gurugram
- APAC Biotech, Noida
- Taighde cille dendritic, Deilí Nua
Costas cóireála imdhíonteiripe dendritic-bhunaithe san India
Féadfaidh an costas a bhaineann le cóireáil imdhíonteiripe dendritic-bhunaithe a bheith éagsúil ó $ 8000 USD - $ 15,000 USD ag brath ar chéim na hailse agus an dochtúir agus an t-ospidéal a thugann cóireáil.
